The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cell-Free DNA (cf-DNA) Testing Market Research Report 2025
Synopsis
The global Cell-Free DNA (cf-DNA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Cell-free DNA (cfDNA) testing, also known as non-invasive prenatal testing (NIPT) when applied in the context of pregnancy, is a relatively new diagnostic tool that involves analyzing fragments of DNA circulating in the bloodstream.
In the context of pregnancy, cfDNA testing is typically used to screen for chromosomal abnormalities in a developing fetus, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). This non-invasive approach, which involves a simple blood draw from the pregnant individual, provides an alternative to invasive procedures like amniocentesis or chorionic villus sampling, which carry a small risk of miscarriage.
Moreover, cfDNA testing holds potential for assessing other genetic conditions and diseases, including cancer, organ transplantation monitoring, and prenatal diagnosis for genetic disorders. Furthermore, it can be used in cancer care to analyze tumor DNA and monitor disease progression, treatment response, and the presence of specific genetic mutations.
The testing process involves isolating and analyzing circulating DNA fragments, assessing the genetic material for specific variations, and then providing information about the risk of genetic conditions or disease states.
The availability and applications of cfDNA testing continue to expand, and ongoing research seeks to explore its potential in other areas of diagnostics and personalized medicine. However, it is important to note that, as with any medical test, cfDNA testing has limitations and should be used in conjunction with clinical assessment and counseling by healthcare professionals.
This report aims to provide a comprehensive presentation of the global market for Cell-Free DNA (cf-DNA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Free DNA (cf-DNA) Testing.
Report Scope
The Cell-Free DNA (cf-DNA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-Free DNA (cf-DNA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Free DNA (cf-DNA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche
Sequenom
Trovagene
Segment by Type
Donor-derived
Circulating
Cell-free
Segment by Application
Oncology
Gynecology
Transplantation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Free DNA (cf-DNA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cell-Free DNA (cf-DNA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Cell-free DNA (cfDNA) testing, also known as non-invasive prenatal testing (NIPT) when applied in the context of pregnancy, is a relatively new diagnostic tool that involves analyzing fragments of DNA circulating in the bloodstream.
In the context of pregnancy, cfDNA testing is typically used to screen for chromosomal abnormalities in a developing fetus, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). This non-invasive approach, which involves a simple blood draw from the pregnant individual, provides an alternative to invasive procedures like amniocentesis or chorionic villus sampling, which carry a small risk of miscarriage.
Moreover, cfDNA testing holds potential for assessing other genetic conditions and diseases, including cancer, organ transplantation monitoring, and prenatal diagnosis for genetic disorders. Furthermore, it can be used in cancer care to analyze tumor DNA and monitor disease progression, treatment response, and the presence of specific genetic mutations.
The testing process involves isolating and analyzing circulating DNA fragments, assessing the genetic material for specific variations, and then providing information about the risk of genetic conditions or disease states.
The availability and applications of cfDNA testing continue to expand, and ongoing research seeks to explore its potential in other areas of diagnostics and personalized medicine. However, it is important to note that, as with any medical test, cfDNA testing has limitations and should be used in conjunction with clinical assessment and counseling by healthcare professionals.
This report aims to provide a comprehensive presentation of the global market for Cell-Free DNA (cf-DNA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Free DNA (cf-DNA) Testing.
Report Scope
The Cell-Free DNA (cf-DNA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-Free DNA (cf-DNA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Free DNA (cf-DNA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche
Sequenom
Trovagene
Segment by Type
Donor-derived
Circulating
Cell-free
Segment by Application
Oncology
Gynecology
Transplantation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Free DNA (cf-DNA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free DNA (cf-DNA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Donor-derived
1.2.3 Circulating
1.2.4 Cell-free
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cf-DNA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Gynecology
1.3.4 Transplantation
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free DNA (cf-DNA) Testing Market Perspective (2019-2030)
2.2 Cell-Free DNA (cf-DNA) Testing Growth Trends by Region
2.2.1 Global Cell-Free DNA (cf-DNA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell-Free DNA (cf-DNA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Cell-Free DNA (cf-DNA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Cell-Free DNA (cf-DNA) Testing Market Dynamics
2.3.1 Cell-Free DNA (cf-DNA) Testing Industry Trends
2.3.2 Cell-Free DNA (cf-DNA) Testing Market Drivers
2.3.3 Cell-Free DNA (cf-DNA) Testing Market Challenges
2.3.4 Cell-Free DNA (cf-DNA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free DNA (cf-DNA) Testing Players by Revenue
3.1.1 Global Top Cell-Free DNA (cf-DNA) Testing Players by Revenue (2019-2024)
3.1.2 Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cell-Free DNA (cf-DNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Free DNA (cf-DNA) Testing Revenue
3.4 Global Cell-Free DNA (cf-DNA) Testing Market Concentration Ratio
3.4.1 Global Cell-Free DNA (cf-DNA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cf-DNA) Testing Revenue in 2023
3.5 Cell-Free DNA (cf-DNA) Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free DNA (cf-DNA) Testing Product Solution and Service
3.7 Date of Enter into Cell-Free DNA (cf-DNA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cf-DNA) Testing Breakdown Data by Type
4.1 Global Cell-Free DNA (cf-DNA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Cell-Free DNA (cf-DNA) Testing Forecasted Market Size by Type (2025-2030)
5 Cell-Free DNA (cf-DNA) Testing Breakdown Data by Application
5.1 Global Cell-Free DNA (cf-DNA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Cell-Free DNA (cf-DNA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell-Free DNA (cf-DNA) Testing Market Size (2019-2030)
6.2 North America Cell-Free DNA (cf-DNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell-Free DNA (cf-DNA) Testing Market Size by Country (2019-2024)
6.4 North America Cell-Free DNA (cf-DNA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Free DNA (cf-DNA) Testing Market Size (2019-2030)
7.2 Europe Cell-Free DNA (cf-DNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell-Free DNA (cf-DNA) Testing Market Size by Country (2019-2024)
7.4 Europe Cell-Free DNA (cf-DNA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Free DNA (cf-DNA) Testing Market Size (2019-2030)
9.2 Latin America Cell-Free DNA (cf-DNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell-Free DNA (cf-DNA) Testing Market Size by Country (2019-2024)
9.4 Latin America Cell-Free DNA (cf-DNA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technology
11.1.1 Agilent Technology Company Detail
11.1.2 Agilent Technology Business Overview
11.1.3 Agilent Technology Cell-Free DNA (cf-DNA) Testing Introduction
11.1.4 Agilent Technology Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.1.5 Agilent Technology Recent Development
11.2 Allenex
11.2.1 Allenex Company Detail
11.2.2 Allenex Business Overview
11.2.3 Allenex Cell-Free DNA (cf-DNA) Testing Introduction
11.2.4 Allenex Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.2.5 Allenex Recent Development
11.3 Biocept
11.3.1 Biocept Company Detail
11.3.2 Biocept Business Overview
11.3.3 Biocept Cell-Free DNA (cf-DNA) Testing Introduction
11.3.4 Biocept Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.3.5 Biocept Recent Development
11.4 Biodesix
11.4.1 Biodesix Company Detail
11.4.2 Biodesix Business Overview
11.4.3 Biodesix Cell-Free DNA (cf-DNA) Testing Introduction
11.4.4 Biodesix Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.4.5 Biodesix Recent Development
11.5 CareDx
11.5.1 CareDx Company Detail
11.5.2 CareDx Business Overview
11.5.3 CareDx Cell-Free DNA (cf-DNA) Testing Introduction
11.5.4 CareDx Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.5.5 CareDx Recent Development
11.6 Guardant Health
11.6.1 Guardant Health Company Detail
11.6.2 Guardant Health Business Overview
11.6.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Introduction
11.6.4 Guardant Health Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.6.5 Guardant Health Recent Development
11.7 Illumania
11.7.1 Illumania Company Detail
11.7.2 Illumania Business Overview
11.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Introduction
11.7.4 Illumania Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.7.5 Illumania Recent Development
11.8 Invited
11.8.1 Invited Company Detail
11.8.2 Invited Business Overview
11.8.3 Invited Cell-Free DNA (cf-DNA) Testing Introduction
11.8.4 Invited Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.8.5 Invited Recent Development
11.9 Natera
11.9.1 Natera Company Detail
11.9.2 Natera Business Overview
11.9.3 Natera Cell-Free DNA (cf-DNA) Testing Introduction
11.9.4 Natera Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.9.5 Natera Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Introduction
11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.10.5 Quest Diagnostics Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Cell-Free DNA (cf-DNA) Testing Introduction
11.11.4 Roche Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.11.5 Roche Recent Development
11.12 Sequenom
11.12.1 Sequenom Company Detail
11.12.2 Sequenom Business Overview
11.12.3 Sequenom Cell-Free DNA (cf-DNA) Testing Introduction
11.12.4 Sequenom Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.12.5 Sequenom Recent Development
11.13 Trovagene
11.13.1 Trovagene Company Detail
11.13.2 Trovagene Business Overview
11.13.3 Trovagene Cell-Free DNA (cf-DNA) Testing Introduction
11.13.4 Trovagene Revenue in Cell-Free DNA (cf-DNA) Testing Business (2019-2024)
11.13.5 Trovagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
